Atara Biotherapeutics (ATRA) Capital Expenditures (2014 - 2024)
Atara Biotherapeutics (ATRA) posted Capital Expenditures of $90000.0 for Q4 2024, down 42.31% on a QoQ basis from $156000.0 in Q2 2024, and up 104.05% year-over-year from $44106.7 in Q1 2024.
Atara Biotherapeutics (ATRA) Capital Expenditures (2014 - 2024) Analysis & Trends
Atara Biotherapeutics' Capital Expenditures history runs 11 years deep, the most recent figure standing at $90000.0 for Q4 2024.
- Quarterly Capital Expenditures rose 104.05% year-over-year to $90000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $90000.0 (up 104.36% YoY) and the FY2024 annual result came in at $246000.0, up 123.59% from the prior year.
- Capital Expenditures was $90000.0 for Q4 2024 at Atara Biotherapeutics, down from $156000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $2.6 million in Q1 2022 and bottomed at -$2.5 million in Q2 2022.
- A 5-year average of $328666.7 and a median of $281000.0 in 2021 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2020 — Capital Expenditures surged 742.72% — and 2023, when it slumped 8646.15%.
- Atara Biotherapeutics' Capital Expenditures stood at $601000.0 in 2020, then tumbled by 53.24% to $281000.0 in 2021, then plunged by 90.75% to $26000.0 in 2022, then slumped by 8646.15% to -$2.2 million in 2023, then jumped by 104.05% to $90000.0 in 2024.
- Business Quant data shows ATRA's Capital Expenditures at $90000.0 in Q4 2024, $156000.0 in Q2 2024, and -$2.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 90,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Dec 31, 2023 | -2.22 Mn |
| Dec 31, 2023 | -2.22 Mn |
| Sep 30, 2023 | 281,000.00 |
| Sep 30, 2023 | 281,000.00 |
| Jun 30, 2023 | 704,000.00 |
| Jun 30, 2023 | 704,000.00 |
| Mar 31, 2023 | 194,000.00 |
| Mar 31, 2023 | 194,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | -97,000.00 |
| Sep 30, 2022 | -97,000.00 |
| Jun 30, 2022 | -2.47 Mn |
| Jun 30, 2022 | -2.47 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Mar 31, 2022 | 2.61 Mn |